Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control?

about

Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control?

Item

http://www.wikidata.org/entity/Q47160017

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Early sorafenib induction afte ...... improve loco-regional control?

@en

Early sorafenib induction afte ...... improve loco-regional control?

@nl

type

Item

label

Early sorafenib induction afte ...... improve loco-regional control?

@en

Early sorafenib induction afte ...... improve loco-regional control?

@nl

prefLabel

Early sorafenib induction afte ...... improve loco-regional control?

@en

Early sorafenib induction afte ...... improve loco-regional control?

@nl

P1476

Early sorafenib induction afte ...... improve loco-regional control?

@en

P2093

Akihiro Moriuchi

http://www.w3.org/2001/XMLSchema#string

Akiko Saishoji

http://www.w3.org/2001/XMLSchema#string

Akio Ido

http://www.w3.org/2001/XMLSchema#string

Eriko Tabu

http://www.w3.org/2001/XMLSchema#string

Haruka Sakae

http://www.w3.org/2001/XMLSchema#string

Hiroka Onishi

http://www.w3.org/2001/XMLSchema#string

Kaori Muromachi

http://www.w3.org/2001/XMLSchema#string

Kazuaki Tabu

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Sakurai

http://www.w3.org/2001/XMLSchema#string

Kohei Oda

http://www.w3.org/2001/XMLSchema#string

P2860

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Global cancer statistics, 2012

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.

Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

P304

1135-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1434

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285389

http://www.w3.org/2001/XMLSchema#string

P932

5740826

http://www.w3.org/2001/XMLSchema#string